chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Microbiology test normal, Oxygen saturation decreased, Pneumonia, Pyrexia
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sputum culture positive, Streptococcus test negative, Troponin normal
Clinical narrative: Patient presented to ED after being seen at an urgent care on 11/26 with cough, congestion, and fevers that started on 11/13. He tested positive for COVID-19 and learned of his results the following day when he presented to the ED the following day on 11/27 for progressive symptoms. Additional symptoms included back pain and diarrhea. He received IV hydration. He had a virtual visit on 11/30, no reported hypoxia at that time, was febrile at 101, started on doxycycline 100 mg q.12 for 7 days. He presented the following day on 12/01 to ED, reporting feeling dehydrated and now with dysuria and worsening shortness of breath. Labs showed hyponatremia at 128, negative troponin, CTA negative for PE, prescribed Reglan. On 12/03 he had another virtual visit with his PCP, no reported hypoxia, worsening appetite, reporting very poor tolerance of oral doxycycline, doxycycline discontinued, started on Vantin. The patient presented to the ED with worsening back pain, cough, and diarrhea. Having worsening malaise, still febrile at home. Patient was admitted for COVID-19 infection/acute hypoxemic respiratory failure/CAP/immunosuppression. On 12/6 patient's oxygen requirements increased to 15L venti mask. Remdesivir was started. IV doxy was started in an effort to avoid GI distress. On 12/7 patient weaned to 6L but with worsening O2 sat was increased back to 15L. CXR ordered and noted to have worsening infiltrates. Respiratory cultures significant for gram negative rods, gram positive cocci and rods, all covered by the prescribed antibiotics. Patient found to be negative for C. pneumonia, C. Trichromatic, C psittaci, Strep pneumo, Aspergillus, and fungitell. Immunosuppressive medications held except for tacrolimus. Tacrolimus trough levels trended, and dose adjusted accordingly. Patient's oxygen requirements increased on 12/10 to non-rebreather mask, and high flow nasal cannula on 12/11. However on 12/12 patient was able to be downgraded to venti mask, and on 12/13 to 6L on NC. Antibiotics were stopped on 12/12 due to microbiology studies being negative. 12/13: Weaned to 6 L NC; Improving SOB. Pt/OT recommended post acute care. 12/14: Weaned to 5-4 L NC; improving SOB. O2 sat decreased to 86% with activity but recovered to 92% within 30 seconds. 12/16: Patient alert and fully oriented breathing room air. Reports that he feels much better, states that he would like to go home. He is eating well and denies CP abdominal pain. Some mild SOB when he is ambulating but is much improved from days prior. Patient was discharged to home on 12/17 in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pyrexia, Urticaria
Clinical narrative: Within hours of injection she was in bed 24 hours a day for 3 nights.   Stabbing headaches, fever, chills and aches & pains in joints, urticaria
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Shoulder pain.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received adult dose instead of pediatric dose.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with positive covid test
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Chest X-ray, Dizziness, Dyspnoea, Spirometry
Clinical narrative: It started after my husband and I were walking and I got dizzy, light headed, and felt like I was going to pass out. I walked less than a mile when that started and my breathing was really labored. When we got to the donut shop, I stayed there and my husband walked back to the house to get the car and pick me up. After that, I called my PCP and he had me take a stress test and that came back perfectly normal. I also had a CT taken to make sure that I didn?t have plaque build up in my arteries. That came back normal. So it wasn?t my heart which I thought it might have been. He suggested I go to a pulmonologist. So I made an appointment with Dr., which was yesterday. She had me do a breathing test and also had an x-ray taken of my lungs and I don?t know the results of that yet. Basically, I guess my complaint or issue is- My husband and I, when the weather is cold, we walk and in warm weather we would ride bikes. I used to be in good health and it just so happened that this seemed to be after my shot. I have lost 80 lbs. I used to weigh 240 lb, and now I?m at 160. It?s important to me to be able to do these activities and be active. That?s how I also noticed how my health as changed and breathing became labored because it didn?t use to be like that.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Myalgia
Clinical narrative: Muscle pain in shoulder and associated loss of range of motion.  Started with first shot.  Second and third doses (end of March and October 2021) were given in right arm.  Experienced same symptoms in right arm.  I noted that this is a known reaction to the vaccine but generally was short lived.  I still have these symptoms after almost a year.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: ITCHING (WHOLE BODY)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Urticaria
Clinical narrative: Eight days after the injection, a burning rash about the size of my palm appeared out of no where.  I could not tolerate topical creams on it and it disappeared after several days. It did not appear or disappear gradually. It didn't impede any arm movement. I had hives accompany the rash that also disappeared after several days.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with positive covid test result
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: About 2 months after the booster, I got COVID. I got night sweats and high fevers for 6 days. I had trouble breathing, my chest hurt a lot. It was extensive pressure on my chest. I was cold and shivering a lot, and about 8 days I felt better. I was non functional during this time. I could not get out of bed, I was to dizzy and fatigued. I was about to go to the hospital because I was in such bad shape, but I did not.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Psoriasis, Rash
Clinical narrative: Within two days of the vaccine, I broke out in a severe rash across my face. Within about a month it had spread all over my neck, chest, arms, and back. Within approximately several more months the rash had spread to my legs.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dizziness, Erythema, Hot flush, Nausea
Clinical narrative: On 2/22/2022 I had a full body anaphylactic skin reaction covering my feet, legs, buttocks, back, arms, hands, scalp, chest, stomach, neck, and face. It began presenting as bright red splotches with raised, moderately swollen itchy bumps in ~3 inch by ~3 inch patches at approximately 11:30 pm, localized to elbows, knees, both upper arms and upper back region. Within an hour it had spread to completely cover my body (as described earlier) and was extremely painful. Skin was red, bumpy,  severely swollen, and extremely irritated to the touch. At this time I was also experiencing lightheadedness, prolonged nausea, and what felt like a heat flash. I took a lukewarm shower and a 24-hour Zyrtec pill at approximately 12 am but did not feel any relief until I woke up a few hours later around 5:30 am to find that the visible skin reaction was gone. It is currently 11:59 am and my skin still itches slightly, but there is no visible reaction anymore.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash, Rash macular, Rash papular
Clinical narrative: On 2/22/2022 I had a full body anaphylactic skin reaction covering my feet, legs, buttocks, back, arms, hands, scalp, chest, stomach, neck, and face. It began presenting as bright red splotches with raised, moderately swollen itchy bumps in ~3 inch by ~3 inch patches at approximately 11:30 pm, localized to elbows, knees, both upper arms and upper back region. Within an hour it had spread to completely cover my body (as described earlier) and was extremely painful. Skin was red, bumpy,  severely swollen, and extremely irritated to the touch. At this time I was also experiencing lightheadedness, prolonged nausea, and what felt like a heat flash. I took a lukewarm shower and a 24-hour Zyrtec pill at approximately 12 am but did not feel any relief until I woke up a few hours later around 5:30 am to find that the visible skin reaction was gone. It is currently 11:59 am and my skin still itches slightly, but there is no visible reaction anymore.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Skin irritation, Skin reaction, Swelling
Clinical narrative: On 2/22/2022 I had a full body anaphylactic skin reaction covering my feet, legs, buttocks, back, arms, hands, scalp, chest, stomach, neck, and face. It began presenting as bright red splotches with raised, moderately swollen itchy bumps in ~3 inch by ~3 inch patches at approximately 11:30 pm, localized to elbows, knees, both upper arms and upper back region. Within an hour it had spread to completely cover my body (as described earlier) and was extremely painful. Skin was red, bumpy,  severely swollen, and extremely irritated to the touch. At this time I was also experiencing lightheadedness, prolonged nausea, and what felt like a heat flash. I took a lukewarm shower and a 24-hour Zyrtec pill at approximately 12 am but did not feel any relief until I woke up a few hours later around 5:30 am to find that the visible skin reaction was gone. It is currently 11:59 am and my skin still itches slightly, but there is no visible reaction anymore.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Cholelithiasis, Hepatic cyst, Hepatic lesion
Clinical narrative: I did test positive for COVID-19 on 09/09/2021. On 11/10/2021, I had gone to urgent care for Cervical pain. They did a cervical spine x-ray and I was told to just take Motrin. On 11/20/2021, I went to a neurosurgeon due to having upper and lower back pain on both sides of my spine. They did an upper spine MRI and they determined I had edema in my spine, a bulging disc and a lesion in my upper spine (never had this before). During the MRI, they saw masses on my liver and requested an abdominal MRI with contrast and found cysts and a lesion on the upper lobe of my liver. I did receive my booster on 01/08/2022. I went to Dr. on 02/01/2022 and he recommended I see oncology/hematology because the X-ray showed that the masses on my spine must have metastasized from somewhere in my body. I saw the oncologist on 02/08/2022 and he drew labs and I am waiting to hear back.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic mass, Intervertebral disc disorder, Intervertebral disc protrusion, Laboratory test, Magnetic resonance imaging abnormal
Clinical narrative: I did test positive for COVID-19 on 09/09/2021. On 11/10/2021, I had gone to urgent care for Cervical pain. They did a cervical spine x-ray and I was told to just take Motrin. On 11/20/2021, I went to a neurosurgeon due to having upper and lower back pain on both sides of my spine. They did an upper spine MRI and they determined I had edema in my spine, a bulging disc and a lesion in my upper spine (never had this before). During the MRI, they saw masses on my liver and requested an abdominal MRI with contrast and found cysts and a lesion on the upper lobe of my liver. I did receive my booster on 01/08/2022. I went to Dr. on 02/01/2022 and he recommended I see oncology/hematology because the X-ray showed that the masses on my spine must have metastasized from somewhere in my body. I saw the oncologist on 02/08/2022 and he drew labs and I am waiting to hear back.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging neck, Mass, Neck pain, Scan with contrast abnormal, X-ray abnormal
Clinical narrative: I did test positive for COVID-19 on 09/09/2021. On 11/10/2021, I had gone to urgent care for Cervical pain. They did a cervical spine x-ray and I was told to just take Motrin. On 11/20/2021, I went to a neurosurgeon due to having upper and lower back pain on both sides of my spine. They did an upper spine MRI and they determined I had edema in my spine, a bulging disc and a lesion in my upper spine (never had this before). During the MRI, they saw masses on my liver and requested an abdominal MRI with contrast and found cysts and a lesion on the upper lobe of my liver. I did receive my booster on 01/08/2022. I went to Dr. on 02/01/2022 and he recommended I see oncology/hematology because the X-ray showed that the masses on my spine must have metastasized from somewhere in my body. I saw the oncologist on 02/08/2022 and he drew labs and I am waiting to hear back.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anal incontinence, Angiogram pulmonary abnormal, Blood creatine phosphokinase increased
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid, Blood pressure decreased, COVID-19, Cognitive disorder, Condition aggravated
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dehydration, Dysarthria, Erythema, Fall
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate decreased, Hyponatraemia, Lactic acidosis, Leukocytosis, Major depression
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic encephalopathy, Oropharyngeal discomfort, Oxygen saturation decreased, Positive airway pressure therapy, Productive cough
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rhabdomyolysis, Sepsis, Skin abrasion, Upper respiratory tract infection
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: Provider hospital summary "Per HPI, Patient is poor historian.  Only complaint has been a rasping in his throat and a cough productive of clear sputum for the past week or two.    Per chart review, was covered in fresh and dried stool with excorations on buttocks and upper thighs and surrounding skin erythema when he arrived in Emergency Department.  EMS reported oxygen saturation of 88% on room air.  Was admitted to the hospital 11/8/2021 when he presented with transient dysarthria; declined MRI of brain at that time.    Has had 2 COVID vaccines but not a booster. Has intentionally lost about 5 lbs in the past months.   Denies recent fever, chills, marked fatigue, sore throat, chest discomfort, shortness of breath, abdominal discomfort, nausea, vomiting, diarrhea, constipation, black or bloody bowel movements, pain with urination, lightheadedness, falls, need to use assistive devices to ambulate.     1. Sepsis: suspect secondary to COVID-19 URI. Pt initially febrile to 102.6F, leukocytosis 42, lactate 8.1. Fever, lactic acidosis resolved.    2. Acute respiratory failure: due to COVID-19. Noted to be saturating at 88% on RA upon arrival however desaturated early AM 11/26 now requiring NIPPV support at max setting.  CTA on admission negative for PE, diffuse ground glass opacity. Possibly developed severe aspiration PNA. Discussed with daughter, explained of patient's grave prognosis in setting of underlying dementia-elected to change code status to DNR/DNI comfort care at this time. Patient kept on BIPAP along with broad spectrum abx, however BP and HR continued to decline. Patient pronounced dead on 11/27/2021 at 11:30 AM.    3. Hyponatremia: suspect due to dehydration   4. Rhabdomyolysis: CPK 8000 on admission. Patient was seen by EMS 2-3 days ago after being found on floor for unknown length of time, though no medical attention sought at that time.    5. Acute renal insufficiency   6. Acute metabolic encephalopathy/FTT: patient had a GLF early this year and cognition has been slowing down. APS case apparently opened.   7. CLL: reportedly not following with oncologist. Relative leukocytosis compared to baseline.    8. CAD: s/p CABG   9. MDD - Cymbalta    10. Acute on chronic thrombocytopenia"
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Hypophagia, SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID on 9/12/2021; given monoclonal antibody injections; no cough, no SOB; poor oral intake; pt's condition worsened and he was found deceased in the facility by one of the nurses
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Injection site erythema, Musculoskeletal stiffness, Pain, Pyrexia
Clinical narrative: Pt had body aches, fever, stiff neck, and redness at injection site.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Benzodiazepine drug level, COVID-19, Drug screen positive, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient presented to GVH ED after being found down at home, unresponsive and incontinent of urine. Patient's UDS was positive for benzos and oxycodone. Patient was found to be COVID positive incidentally. Previously was vaccinated with Pfizer on 3/1/21 and 3/27/21. Admitted to GVH 1/10/22 and discharged 1/13/22.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli, Urinary incontinence
Clinical narrative: Patient presented to GVH ED after being found down at home, unresponsive and incontinent of urine. Patient's UDS was positive for benzos and oxycodone. Patient was found to be COVID positive incidentally. Previously was vaccinated with Pfizer on 3/1/21 and 3/27/21. Admitted to GVH 1/10/22 and discharged 1/13/22.
Age: 0.33
Sex: M
Vaccine: HIBV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Child received ACT Hib in addition to Pentacel vaccine
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: Patient does not call or refers any adverse problem. No viable vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Blood culture positive, COVID-19, COVID-19 pneumonia, Clostridium test
Clinical narrative: Provider hospital summary "Patient with Tongue cancer  Metastatic cancer to cervical lymph nodes who is Gastrostomy tube dependent for nutrition developed confusion and hypoxia.     Active Problems: It was felt this might be Sepsis with metabolic encephalopathy.  The hypoxia appeared to be due to Pneumonia due to COVID-19 virus as she was COVID positive.  Other possible sources of sepsis considered,  E. coli UTI (urinary tract infection) and had positive blood cultures.  One culture with staph epi. which was considered likely contaminant but the another culture grew actintignum schaalii which can be a uropathogen, usually responsive to beta lactams.  There was also some concern for a superimposed bacterial pneumonia. She has completed a course of PIPERACILLIN-TAZOBACTAM which was then discontinued.  She was noted to have a an increasing leukocytosis even after discontinuing the DECADRON that was started for the COVID infection.  She also completed a course of REMDESIVIR.   She remained afebrile but had tachycardia at rest. Patient had no respiratory symptoms such as cough or pleuritic chest pain. She did not require supplemental oxygen. She did not appear acutely ill.  Considered ultrasound for deep venous thrombosis of lower extremities but had no edema or calve tenderness.She had some loose stools but testing for C. Difficile was negative.  Ordered computed tomography angiogram of chest which was negative for pulmonary embolism, noting, "Patchy density throughout the right lung compatible with infiltrates." The patient was anxious to leave the hospital and did not appear acutely ill so she prescribed AMOXICILLIN-CLAVULANATE for seven days and she was requested to have a follow up blood count in 3-5 days through her primary care provider"
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Diarrhoea, Hypoxia, Leukocytosis, Lung infiltration
Clinical narrative: Provider hospital summary "Patient with Tongue cancer  Metastatic cancer to cervical lymph nodes who is Gastrostomy tube dependent for nutrition developed confusion and hypoxia.     Active Problems: It was felt this might be Sepsis with metabolic encephalopathy.  The hypoxia appeared to be due to Pneumonia due to COVID-19 virus as she was COVID positive.  Other possible sources of sepsis considered,  E. coli UTI (urinary tract infection) and had positive blood cultures.  One culture with staph epi. which was considered likely contaminant but the another culture grew actintignum schaalii which can be a uropathogen, usually responsive to beta lactams.  There was also some concern for a superimposed bacterial pneumonia. She has completed a course of PIPERACILLIN-TAZOBACTAM which was then discontinued.  She was noted to have a an increasing leukocytosis even after discontinuing the DECADRON that was started for the COVID infection.  She also completed a course of REMDESIVIR.   She remained afebrile but had tachycardia at rest. Patient had no respiratory symptoms such as cough or pleuritic chest pain. She did not require supplemental oxygen. She did not appear acutely ill.  Considered ultrasound for deep venous thrombosis of lower extremities but had no edema or calve tenderness.She had some loose stools but testing for C. Difficile was negative.  Ordered computed tomography angiogram of chest which was negative for pulmonary embolism, noting, "Patchy density throughout the right lung compatible with infiltrates." The patient was anxious to leave the hospital and did not appear acutely ill so she prescribed AMOXICILLIN-CLAVULANATE for seven days and she was requested to have a follow up blood count in 3-5 days through her primary care provider"
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metastatic lymphoma, SARS-CoV-2 test positive, Staphylococcus test positive, Tachycardia, Tongue cancer metastatic
Clinical narrative: Provider hospital summary "Patient with Tongue cancer  Metastatic cancer to cervical lymph nodes who is Gastrostomy tube dependent for nutrition developed confusion and hypoxia.     Active Problems: It was felt this might be Sepsis with metabolic encephalopathy.  The hypoxia appeared to be due to Pneumonia due to COVID-19 virus as she was COVID positive.  Other possible sources of sepsis considered,  E. coli UTI (urinary tract infection) and had positive blood cultures.  One culture with staph epi. which was considered likely contaminant but the another culture grew actintignum schaalii which can be a uropathogen, usually responsive to beta lactams.  There was also some concern for a superimposed bacterial pneumonia. She has completed a course of PIPERACILLIN-TAZOBACTAM which was then discontinued.  She was noted to have a an increasing leukocytosis even after discontinuing the DECADRON that was started for the COVID infection.  She also completed a course of REMDESIVIR.   She remained afebrile but had tachycardia at rest. Patient had no respiratory symptoms such as cough or pleuritic chest pain. She did not require supplemental oxygen. She did not appear acutely ill.  Considered ultrasound for deep venous thrombosis of lower extremities but had no edema or calve tenderness.She had some loose stools but testing for C. Difficile was negative.  Ordered computed tomography angiogram of chest which was negative for pulmonary embolism, noting, "Patchy density throughout the right lung compatible with infiltrates." The patient was anxious to leave the hospital and did not appear acutely ill so she prescribed AMOXICILLIN-CLAVULANATE for seven days and she was requested to have a follow up blood count in 3-5 days through her primary care provider"
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Severe vertigo; lasted approximately 5-6 hours.  Slept and the next am it was resolved.   Vertigo when head elevated; when lying down with eyes closed it was less impactful.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood pressure increased, Cognitive disorder, Heart rate increased, Immediate post-injection reaction
Clinical narrative: An immediate reaction to the vaccine; experienced swollen lymph nodes and throat. Loss of cognitive thinking, next morning experienced increase in the swollen glands. Increase in heart rate, Blood Pressure and Blood Sugar. Menses brought on by vaccine as well.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Menstruation irregular
Clinical narrative: An immediate reaction to the vaccine; experienced swollen lymph nodes and throat. Loss of cognitive thinking, next morning experienced increase in the swollen glands. Increase in heart rate, Blood Pressure and Blood Sugar. Menses brought on by vaccine as well.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angioedema, Blood test, Computerised tomogram, Laboratory test, Magnetic resonance imaging
Clinical narrative: 3 oral angioedema attacks since approximately Nov. 2021, the 2nd and 3rd treated in ER and admitted to hospital.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Azotaemia, Blood urea increased, COVID-19
Clinical narrative: Provider hospital summary ".
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Condition aggravated, Cough, Headache, Hypercalcaemia
Clinical narrative: Provider hospital summary ".
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Light chain analysis abnormal, Mechanical ventilation, Mental status changes, Pain
Clinical narrative: Provider hospital summary ".
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia bacterial, SARS-CoV-2 test positive, Superinfection
Clinical narrative: Provider hospital summary ".
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Confusional state, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Case was vaccinated and boosted with Covid vaccine, then hospitalized for Covid 7 weeks after being boosted.  Admitted 12/17/21 for confusion and weakness, found to be hypoxic and Covid positive. Required up to 4 litres of oxygen, and weaned back down to room air.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Death, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: pt died at home; had a positive COVID test on 1/2/22 and was quarantined at home; family found pt on the floor unresponsive; EMS called; pt in asystole and pronounced deceased at the home; per death certificate, contributing condition was recent COVID 19 infection
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated patient admitted with positive Covid-19 infection.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Facial paralysis, Paralysis
Clinical narrative: After receiving the vaccine, I had a slowly developing paralysis on the left half of my face occurring over a 2 to 3 day period. I was unable to close my left eye, and I couldn't talk because my mouth was paralyzed on the left side. My doctor said it was a grade 4 paralysis. It was diagnosed as Bell's palsy. I was prescribed prednisone and an anti-viral medication on the 4th day. The study of improvement occurred over the next 10 days. After 10 days the paralysis had ended with the help of the medications. I don't notice anymore paralysis on my face, and I am functioning back to normal now.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Abulia, Asthenia, Influenza like illness, Sensory disturbance
Clinical narrative: I went to the Hospital to get my 2nd Covid shot.  I waited the 15 minutes and then when home and I was fine. The next morning when I woke up I was feeling vale over my face.  I was with no energy, indecisive vague, mostly Flu like symptom this lasted about 3 days and then started to feel better.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Nausea, Pain, Vomiting
Clinical narrative: Patient presented to ED on 1/23/22 with generalized body aches, nausea, vomiting, and headache. PMH is significant for HIV, hepatitis C, and asthma. Patient fully vaccinated with Pfizer on 8/22/21 and 9/12/22. Transferred to ED for admission on 1/23/22. Discharged on 1/25/22.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient faclity and tested positve for covid
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Eye swelling, Eyelid margin crusting, Eyelid retraction
Clinical narrative: Within a couple of weeks after the vaccine, I began having double vision issues in my right eyes as well as eye-swelling and crusty eyes. Retracted eyelid on left eye started between 2nd and booster. Started developing inflammation in eyes after eating gluten.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Convalescent plasma transfusion
Clinical narrative: pt to hospital with c/o weakness, fatigue, dry cough, some SOB x 3-4 days; has fallen at home twice during his weakness; positive for COVID in ED; COVID pneumonia on x-ray; admitted to hosp; pt's O2 requirements increased to requiring a NRB plus high flow O2; pt's condition worsened; required CPAP; transferred to ICU; convalescent plasma given; DNR; pt died in the hosp peacefully with family
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Dyspnoea, Fall, Fatigue
Clinical narrative: pt to hospital with c/o weakness, fatigue, dry cough, some SOB x 3-4 days; has fallen at home twice during his weakness; positive for COVID in ED; COVID pneumonia on x-ray; admitted to hosp; pt's O2 requirements increased to requiring a NRB plus high flow O2; pt's condition worsened; required CPAP; transferred to ICU; convalescent plasma given; DNR; pt died in the hosp peacefully with family
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: pt to hospital with c/o weakness, fatigue, dry cough, some SOB x 3-4 days; has fallen at home twice during his weakness; positive for COVID in ED; COVID pneumonia on x-ray; admitted to hosp; pt's O2 requirements increased to requiring a NRB plus high flow O2; pt's condition worsened; required CPAP; transferred to ICU; convalescent plasma given; DNR; pt died in the hosp peacefully with family
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Affective disorder, COVID-19, COVID-19 pneumonia, Condition aggravated
Clinical narrative: Provider hospital summary "Patient is a 67 YO female with h/o DM2, HTN, PVD, COPD, depression/anxiety/FM, admitted with pneumonia and acute hypoxic respiratory failure due to COVID-19 pneumonia. She was treated with supplemental oxygen, decadron, remdesivir and supportive care. She was slow to improve and noted to have failure to thrive due to her current illness, grief with recent death of a loved one, and chronic health conditions (GPA). Nutrition was consulted and she was started on remeron with significant improvement in appetite and mood. She improved slowly with treatment. Oxygen was weaned to 4L NC for >24 hours prior to discharge. Discharged home in stable condition. Has 2 more days of decadron. Will participate with home care on discharge. Follow-up with PCP and pulmonary. "